A randomized, multicenter, phase II trial of camrelizumab (Cam) with and without metastasis-directed therapy (MDT) in recurrent/metastatic nasopharyngeal carcinoma (R/M-NPC).

被引：0
|
作者：
Zhang, Xin [1 ]
Yan, Jin [2 ]
Lei, Qianqian
Zhang, Lu
Yang, Jieying
Tan, Sze Huey
Chua, Melvin L. K.
Wang, Ying
Sui, Jiangdong
机构：
[1] Chongqing Univ, Coll Med, Chongqing, Peoples R China
[2] Natl Canc Ctr Singapore, Singapore, Singapore
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 23_SUPPL期
关键词：
D O I：
10.1200/JCO.2024.42.23_suppl.141
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [1] A Randomized, Multicenter, Phase 2 Trial of Camrelizumab With or Without Metastasis- directed Stereotactic Body Radiation Therapy in Recurrent or Metastatic Nasopharyngeal Carcinoma
    Zhang, Xin
    Yan, Jin
    Lei, Qianqian
    Neo, Jialing
    Tan, Sze Huey
    Shu, Xiaolei
    Huang, Luo
    Long, Bin
    Xie, Yue
    Wang, Feng
    Wang, Yuwei
    Tu, Honglei
    Wang, Chengchen
    Zhang, Lu
    Yang, Jieying
    Zhang, Jianwen
    Liu, Huawen
    Lim, Darren W. T.
    Chua, Melvin L. K.
    Sui, Jiang Dong
    Wang, Ying
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2025, 121 (04): : 980 - 990
  • [2] Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
    Ost, Piet
    Reynders, Dries
    Decaestecker, Karel
    Fonteyne, Valerie
    Lumen, Nicolaas
    De Bruycker, Aurelie
    Lambert, Bieke
    Delrue, Louke
    Bultijnck, Renee
    Claeys, Tom
    Goetghebeur, Els
    Villeirs, Geert
    De Man, Kathia
    Ameye, Filip
    Billiet, Ignace
    Joniau, Steven
    Vanhaverbeke, Friedl
    De Meerleer, Gert
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05) : 446 - +
  • [3] Phase II open-label randomized study of pembrolizumab with or without bevacizumab in platinum-resistant recurrent/metastatic nasopharyngeal carcinoma (R/M NPC)
    Chong, W. Q.
    Low, J. L.
    Sooi, K.
    Soo, R. A.
    Le, C.
    Teo, H. L.
    Samol, J.
    Goh, G.
    Kong, L. R.
    DasGupta, R.
    Chia, S.
    Wong, R.
    Gopinathan, A.
    Tay, J. K.
    Eu, D.
    Tsang, R.
    Loh, K-S.
    Tai, B. C.
    Lim, Y. C.
    Goh, B-C.
    ANNALS OF ONCOLOGY, 2024, 35 : S614 - S614
  • [4] Apatinib combined with camrelizumab in the treatment of recurrent/metastatic nasopharyngeal carcinoma: a prospective multicenter phase II study
    Mo, Yunyan
    Pan, Yufei
    Zhang, Bin
    Zhang, Jian
    Su, Yixin
    Liu, Zhengchun
    Luo, Meiqing
    Qin, Guanjie
    Kong, Xiangyun
    Zhang, Rongjun
    Pan, Yu
    Liang, Yi
    Wang, Defeng
    Wei, Yuejia
    Chen, Hengwei
    Jiang, Wei
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [5] Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer (EXTEND): A Multicenter, Randomized Phase II Trial
    Tang, C.
    Sherry, A. D.
    Haymaker, C.
    Bathala, T.
    Liu, S.
    Fellman, B.
    Aparicio, A.
    Zurita-Saavedra, A.
    Chun, S.
    Reddy, J.
    Efstathiou, E.
    Wang, J.
    Pilie, P.
    Reuben, A.
    Kovitz, C.
    Kumar, R.
    Chapin, B.
    Gomez, D. R.
    Wistuba, I.
    Corn, P. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (05): : 1059 - 1060
  • [6] Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial
    Ludmir, Ethan B.
    Sherry, Alexander D.
    Fellman, Bryan M.
    Liu, Suyu
    Bathala, Tharakeswara
    Haymaker, Cara
    Medina-Rosales, Marina N.
    Reuben, Alexandre
    Holliday, Emma B.
    Smith, Grace L.
    Noticewala, Sonal S.
    Nicholas, Sarah
    Price, Tracy R.
    Martin-Paulpeter, Rachael M.
    Perles, Luis A.
    Lee, Sunyoung S.
    Lee, Michael S.
    Smaglo, Brandon G.
    Huey, Ryan W.
    Willis, Jason
    Zhao, Dan
    Cohen, Lorenzo
    Taniguchi, Cullen M.
    Koay, Eugene J.
    Katz, Matthew H. G.
    Wolff, Robert A.
    Das, Prajnan
    Pant, Shubham
    Koong, Albert C.
    Tang, Chad
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (32)
  • [7] Re: Surveillance or Metastasis-directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
    Walz, Jochen
    EUROPEAN UROLOGY, 2018, 74 (02) : 235 - 236
  • [8] Addition of Metastasis-Directed Therapy to Standard of Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase II Trial
    Reddy, J. P.
    Liu, S.
    Bathala, T.
    Smith, B. D.
    Ramirez, D.
    Shaitelman, S. F.
    Chung, S. G.
    Brewster, A. M.
    Barcenas, C. H.
    Ghia, A. J.
    Ludmir, E. B.
    Pate, A. B.
    Shah, S. J.
    Woodward, W. A.
    Gomez, D. R.
    Tang, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S136 - S137
  • [9] A phase Ib/II study of GFH018 in combination with toripalimab in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC).
    Mai, Hai-Qiang
    Guo, Ye
    Yang, Muh-Hwa
    Yang, Kunyu
    Chen, Li-Tzong
    Mun, Hui
    Yang, Yan
    Wang, Shuang
    Zhu, Huaqiang
    Shen, Haige
    Wang, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Re: Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2018, 200 (02): : 245 - 246
12345